Results 71 to 80 of about 5,629 (238)
Molecular Oncology, Volume 19, Issue 3, Page 635-658, March 2025.Screening colorectal tumors for glycoproteins linked to disease progression has revealed several potential therapeutic targets. The secretin receptor (SCTR), identified as a marker of poor prognosis and metastasis in colorectal cancer, has been shown to be a key carrier of N‐glycans with sialylated Lewis antigens. These cancer‐specific glycoproteoforms
Sofia Cotton +12 more
wiley +1 more source
Sporadic duodenal macrogastrinoma: a rare case report
Acta Medica Lituanica, 2013 Gastrinomas are rare neuroendocrine tumors characterized by the secretion of gastrin, which causes hyperchlorhydria, thereby producing the Zollinger-Ellison syndrome. In most cases this syndrome manifests as severe peptic ulcer disease. We are presenting
Dainius Šimčikas +5 more
doaj +1 more source
Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr 3]octreotate [PDF]
, 2008 Introduction: Receptor radionuclide therapy is a promising treatment modality for patients with neuroendocrine tumors for whom alternative treatments are limited.
Aken, M.O. (Maarten) van +7 more
core +1 more source
GASTRINOMAS Clinical syndromes [PDF]
Acta Oncologica, 1989 During the last 17 years about 100 gastrinomas have been diagnosed in Denmark. With background of the Danish material and the literature the clinical features and pathology of gastrinoma are reviewed and its medical and surgical treatment discussed.
openaire +2 more sources
Annals of Gastroenterological Surgery, Volume 9, Issue 2, Page 339-346, March 2025.Distribution of Ki‐67 proliferation indices in EUS‐TA versus surgical histological assessment. Abstract Aim Evidence regarding the reliability of endoscopic ultrasound‐guided tissue acquisition (EUS‐TA) for assessing histological proliferation and WHO grading of small (≤20 mm) pancreatic neuroendocrine tumors (PanNETs) is limited.
Yoshihide Nanno +9 more
wiley +1 more source
Annals of Surgery, 1983 Exploratory laparotomy and a search for gastrinomas was performed in 52 patients with the Zollinger-Ellison syndrome (ZES). Gastrinoma tissue was resected in 11 patients (21%), 6 (12%) of whom appear to have been cured. After surgery, serum gastrin levels in these six patients have remained normal from 10 months to 10 years.
C W, Deveney +5 more
openaire +3 more sources
International Journal of Cancer, Volume 156, Issue 5, Page 980-992, 1 March 2025.What's New? Epigenetic regulation has been suggested to play a major role in the pathogenesis of gastroenteropancreatic neuroendocrine tumours, but the underlying mechanisms remain poorly understood. Here, the authors show in two independent cohorts that the calcium‐sensing receptor (CaSR) is down‐regulated in gastroenteropancreatic neuroendocrine ...
Katherine A. English +15 more
wiley +1 more source
World Journal of Surgical Oncology, 2019 Background Zollinger-Ellison syndrome (ZES) is a rare condition characterized by hypersecretion of gastrin by gastrinoma tumors leading to severe peptic ulcer disease with potential development of gastric carcinoid tumors.
Lynsey M. Daniels +6 more
doaj +1 more source
Zollinger-Ellison syndrome: Revelation of the gastrinoma triangle
Radiology Case Reports, 2015 Zollinger-Ellison syndrome is a complex condition in which one or more tumors form in the patient's pancreas or upper duodenum. These tumors, called gastrinomas, secrete excessive amounts of gastrin, and almost all develop ulcers.
Rong-Hsin Yang, MD, Yum-Kung Chu, MD
doaj +1 more source
Primary hepatic gastrinoma, extremely rare case presentation and its surgical resolution, in a third level hospital in Mexico [PDF]
, 2023 Rogelio González-López +7 more
openalex +1 more source